Review Article
Prevalence of Fluoroquinolone-Resistant Campylobacter Species in Iran: A Systematic Review and Meta-Analysis
Table 2
Antibiotic resistance profiles of C. coli.
| Year | City | Strains (n) | Origin | AST | Antibiotic resistance (n) | AMP | AMX | CST | NFX | SPT | NEO | STR | CHL | TET | TMP-SMX | CTX | ERY | CIP | IPM | GEN | MEM | CEF | NAL | CAZ | LEX |
| 2007-2008 | Ahvaz | 21 | Animal | Disk diffusion | 4 | 0 | ND | 3 | ND | ND | 1 | 0 | 14 | ND | ND | 0 | 4 | ND | 0 | ND | ND | 11 | ND | ND | 2007-2008 | Ahvaz | 5 | Human | Disk diffusion E-test | 5 | ND | ND | ND | ND | ND | ND | ND | 3 | ND | 3 | 4 | 1 | ND | 1 | ND | 5 | 2 | 4 | ND | 2009-2010 | Ahvaz-Shahrekord | 7 | Animal | Disk diffusion | 0 | 1 | ND | 0 | ND | ND | 1 | 0 | 3 | ND | ND | 1 | 3 | ND | 0 | ND | ND | 1 | ND | ND | 2016 | Hamadan | 19 | Animal | Disk diffusion | 10 | 8 | 12 | ND | ND | ND | 4 | 1 | 5 | 13 | ND | 2 | 7 | ND | 0 | ND | 12 | 1 | ND | ND | 2013-2014 | Hamadan | 3 | Human | Disk diffusion | ND | ND | ND | ND | ND | ND | ND | 0 | 2 | ND | ND | 3 | 2 | ND | 1 | 2 | ND | 1 | ND | ND | 2014-2015 | Isfahan | 6 | Animal | Disk diffusion | 0 | 0 | ND | 0 | ND | ND | 0 | 0 | 3 | ND | ND | 0 | 0 | ND | 0 | ND | ND | 2 | ND | ND | 2006–2008 | Isfahan | 4 | Animal | Disk diffusion | 0 | 1 | ND | 2 | ND | ND | 0 | 0 | 2 | ND | ND | 0 | 1 | ND | 0 | ND | ND | 1 | ND | ND | 2011-2012 | Isfahan-Shahrekord | 3 | Animal | Disk diffusion | 0 | 0 | ND | 1 | ND | ND | 0 | 0 | 1 | ND | ND | 1 | 1 | ND | 0 | ND | ND | 1 | ND | ND | 2008-2009 | Isfahan-Yazd | 8 | Animal | Disk diffusion | 0 | 0 | ND | 1 | ND | ND | 0 | 0 | 6 | ND | ND | 0 | 2 | ND | 0 | ND | ND | 2 | ND | ND | 2015-2016 | Kurdistan | 8 | Animal | Disk diffusion agar dilution | 5 | 6 | ND | ND | ND | ND | ND | ND | 7 | ND | ND | 0 | 6 | ND | 0 | 0 | ND | ND | ND | ND | 2013 | Mashhad | 27 | Animal | Disk diffusion | 3 | 6 | ND | 4 | ND | 5 | ND | 3 | 17 | ND | ND | 9 | 12 | ND | 1 | ND | ND | 13 | ND | ND | 2012 | Mashhad | 27 | Animal | Disk diffusion | 2 | 1 | 9 | 7 | 1 | 0 | 2 | 1 | 13 | ND | ND | 0 | 15 | ND | 0 | ND | ND | 18 | ND | ND | 2014-2015 | Mazandaran-Golestan | 41 | Animal | Disk diffusion | 17 | 15 | ND | 16 | ND | ND | 15 | ND | 36 | ND | ND | 2 | 36 | ND | 2 | ND | ND | 32 | ND | ND | 2010 | Rafsanjan | 12 | Animal | Disk diffusion | ND | ND | ND | ND | ND | ND | ND | ND | ND | 12 | ND | 0 | 0 | ND | 12 | ND | ND | 0 | ND | ND | 2014 | Shahrekord | 13 | Animal | Disk diffusion | 0 | 3 | ND | 4 | ND | ND | 0 | 0 | 7 | ND | ND | 0 | 5 | ND | 0 | ND | ND | 4 | ND | ND | 2009-2010 | Shahrekord | 15 | Animal | Disk diffusion | 2 | 0 | ND | 2 | ND | ND | 1 | 0 | 7 | ND | ND | 0 | 4 | ND | 0 | ND | ND | 5 | ND | ND | ND | Shahrekord | 4 | Animal | Disk diffusion | 0 | 0 | ND | 1 | ND | ND | 0 | 0 | 2 | ND | ND | 0 | 0 | ND | 0 | ND | ND | 2 | ND | ND | 2011–2013 | Shiraz | 17 | Animal | Disk diffusion | 5 | ND | 0 | 3 | ND | 0 | ND | 1 | 2 | ND | 4 | 5 | 14 | ND | 1 | ND | 10 | 8 | ND | ND | ND | Shiraz | 10 | Animal | Disk diffusion E-test | 1 | ND | ND | ND | ND | ND | ND | 2 | 1 | 1 | 6 | 1 | 0 | ND | 1 | ND | ND | ND | ND | 4 | ND | Shiraz | 10 | Animal | Disk diffusion E-test | 1 | ND | ND | ND | ND | ND | ND | 2 | 1 | ND | 6 | 1 | 0 | ND | 1 | ND | ND | ND | ND | 4 | 2011-2012 | Tehran | 28 | Animal | Disk diffusion | 1 | 5 | 4 | ND | 2 | 2 | 1 | 1 | 6 | ND | ND | 1 | 13 | ND | 1 | ND | ND | 24 | ND | ND | 2012 | Tehran | 39 | Animal | Disk diffusion | 32 | 30 | ND | ND | ND | ND | 35 | 27 | 38 | 31 | ND | 33 | 34 | ND | 0 | ND | ND | 36 | ND | ND | 2010 | Tehran | 33 | Animal | Disk diffusion | 25 | ND | ND | ND | ND | 0 | ND | ND | 31 | ND | ND | ND | 10 | ND | ND | ND | ND | 0 | ND | ND | 2008–2010 | Tehran | 23 | Animal | Disk diffusion | 1 | 3 | 8 | ND | ND | 1 | 1 | 0 | 15 | ND | ND | 1 | 15 | ND | 0 | ND | ND | 18 | ND | ND | 2008-2009 | Tehran | 12 | Human | Disk diffusion | 2 | ND | 2 | ND | ND | 1 | 1 | 1 | 3 | ND | 6 | 1 | 6 | 0 | 0 | ND | ND | 6 | 5 | ND | 2006-2007 | Tehran | 22 | Animal | Disk diffusion | 0 | 3 | 2 | ND | 1 | 1 | 0 | 0 | 4 | ND | ND | 0 | 9 | ND | 0 | ND | ND | 18 | ND | ND | 2004-2005 | Tehran | 5 | Human | Disk diffusion | 1 | ND | 0 | ND | ND | 0 | 0 | 0 | 0 | ND | 2 | 0 | 4 | 0 | 0 | ND | 5 | 5 | 4 | 5 | ND | Tonekabon | 8 | Animal | Disk diffusion E-test | 8 | ND | ND | ND | ND | ND | ND | 2 | 1 | ND | 7 | 2 | 0 | ND | 1 | ND | ND | ND | ND | 8 | ND | Tonekabon | 9 | Animal | Disk diffusion | 9 | 9 | ND | ND | ND | ND | 1 | 2 | 1 | ND | ND | 1 | 0 | ND | 0 | ND | ND | ND | ND | 9 |
|
|
Abbreviations: AMP: ampicillin; AMX: amoxicillin; CST: colistin; NFX: enrofloxacin; SPT: spectinomycin; NEO: neomycin; STR: streptomycin; CHL: chloramphenicol; TET: tetracycline; TMP/SMX: trimethoprim/sulfamethoxazole; CTX: cefotaxime; ERY: erythromycin; CIP: ciprofloxacin; IPM: imipenem; GEN: gentamicin; MEM: meropenem; CEF: cephalothin; NAL: nalidixic acid; CAZ: ceftazidime; LEX: cephalexin; AST: antimicrobial susceptibility testing; ND: not determined.
|